The DOI matches its Crossref record.
The Global Threat of Counterfeit Drugs: Why Industry and Governments Must Communicate the Dangers
Open accessAbstract
The Policy Forum allows health policy makers around the world to discuss challenges and opportunities for improving health care in their societies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The threat of antimicrobial resistance in developing countries: causes and control strategies
Ayukekbong, J. A., Ntemgwa, M., & Atabe, A. N. (2017) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-017-0208-x · Cited by 1,315
Hotez, P. J., Molyneux, D. H., Fenwick, A., Ottesen, E., Ehrlich Sachs, S., & Sachs, J. D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030102 · Cited by 817
Ozawa, S., Evans, D. R., Bessias, S., Haynie, D. G., Yemeke, T. T., Laing, S. K., & Herrington, J. E. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.1662 · Cited by 356
Substandard drugs: a potential crisis for public health
Johnston, A., & Holt, D. W. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12298 · Cited by 270
Performance of retail pharmacies in low- and middle-income Asian settings: a systematic review
Miller, R., & Goodman, C. (2016) · Health Policy and Planning · doi:10.1093/heapol/czw007 · Cited by 225
Metadata
- Authors
- Cockburn, R., Newton, P. N., Agyarko, E. K., Akunyili, D., & White, N. J.
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2005-03-14
- Volume
- 2
- Issue
- 4
- Pages
- e100
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W2139048806
- Cited by
- 330
- References
- 0
- FWCI
- 11.97
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Global Threat of Counterfeit Drugs: Why Industry and Governments Must Communicate the Dangers. https://app.cochat.ai/papers/10.1371/journal.pmed.0020100
- The paper
- Cockburn, R., Newton, P. N., Agyarko, E. K., Akunyili, D., & White, N. J. (2005). The Global Threat of Counterfeit Drugs: Why Industry and Governments Must Communicate the Dangers. PLoS Medicine. https://doi.org/10.1371/journal.pmed.0020100
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
